Skip to content
OpenCapital
Get started

ClearPoint Neuro CLPT Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price

Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price at other companies

Neuropace, Inc. logo
Neuropace, Inc.NPCE
——
ITG
Integer HoldingsITGR
——
Globus Medical logo
Globus MedicalGMED
——
Ginkgo Bioworks logo
Ginkgo BioworksDNA
——
BioLife Solutions logo
BioLife SolutionsBLFS
——
Medpace Holdings, Inc. logo
Medpace Holdings, Inc.MEDP
——

Other financials

Income statement

See full
Revenue$12.1M+42.9%
Gross profit$7.8M+51.1%
Operating income-$8.5M-37.6%
Net income-$9.6M-58.5%
EPS (diluted)-$0.32-45.5%

Balance sheet

See full
Cash & equivalents$36.5M+195%
Total debt$63.6M+1,750%
Total equity$18.8M-5.7%
Total assets$93.4M+211%

Cash flow

See full
Operating cash flow-$8.0M-29.1%
CapEx$645.0K+252%
Free cash flow-$8.6M-35.5%

Valuation

See full
Market cap$538.61M+69.2%
Enterprise value$565.68M+82.9%
P/S13.3×+3.4×

Profitability

See full
Gross margin62.3%+1.1pp
Operating margin-65.2%-1.9pp
Net margin-71.6%+8.8pp
FCF margin-65.7%+269pp

Returns & leverage

See full
Return on equity-149.7%+4,074pp
Debt / equity3.4×+3.2×
Current ratio5.8×+2.3×

Where this comes from

Reported directly by ClearPoint Neuro in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.

The official record: ClearPoint Neuro’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about ClearPoint Neuro's share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ClearPoint Neuro's share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price?
ClearPoint Neuro (CLPT) reported share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price of $5.85 in Q1 2026.
How has ClearPoint Neuro's share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price changed year-over-year?
ClearPoint Neuro's share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price decreased by 5.0% year-over-year, from $6.16 to $5.85.
What is the long-term trend for ClearPoint Neuro's share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price?
Over 5 years (2020 to 2025), ClearPoint Neuro's share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price has grown at a -4.1% compound annual growth rate (CAGR), from $7.12 to $5.78.